Genetic testing providers face tough future in Germany
This article was originally published in Clinica
Executive Summary
Private German genetic testing lab IMMD (Institute for Medical Molecular Diagnostics) has added colon cancer screening to its range of test services. The company now offers molecular genetic testing for around 25 conditions, including hereditary breast and ovarian cancer, non-polyposis colon cancer and Factor V Leiden mutation (venous thrombosis).